Bluejay Diagnostics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Bluejay Diagnostics Depreciation & Amortization Growth & History (BJDX)
Bluejay Diagnostics's depreciation and amortization was $74,182 for fiscal 2025.
View full Bluejay Diagnostics company overviewBluejay Diagnostics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $74,182 | −$1,436 | −1.90% |
| 2024 | 2024-12-31 | $75,618 | −$573,090 | −88.34% |
| 2023 | 2023-12-31 | $648,708 | $492,110 | +314.25% |
| 2022 | 2022-12-31 | $156,598 | $10,879 | +7.47% |
| 2021 | 2021-12-31 | $145,719 | −$11,320 | −7.21% |
| 2020 | 2020-12-31 | $157,039 | — | — |
Bluejay Diagnostics quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28,193 | $10,451 | +58.91% |
| Q1 2026 | 2026-03-31 | $27,763 | $9,362 | +50.88% |
| Q4 2025 | 2025-12-31 | $48,809 | — | — |
| Q3 2025 | 2025-09-30 | $10,624 | −$7,041 | −39.86% |
| Q2 2025 | 2025-06-30 | $17,742 | −$722 | −3.91% |
| Q1 2025 | 2025-03-31 | $18,401 | −$1,313 | −6.66% |
| Q3 2024 | 2024-09-30 | $17,665 | −$235,509 | −93.02% |
| Q2 2024 | 2024-06-30 | $18,464 | −$275,038 | −93.71% |
| Q1 2024 | 2024-03-31 | $19,714 | −$140,631 | −87.71% |
| Q3 2023 | 2023-09-30 | $253,174 | $211,050 | +501.02% |
| Q2 2023 | 2023-06-30 | $293,502 | $249,681 | +569.77% |
| Q1 2023 | 2023-03-31 | $160,345 | $120,374 | +301.15% |
| Q3 2022 | 2022-09-30 | $42,124 | $3,989 | +10.46% |
| Q2 2022 | 2022-06-30 | $43,821 | $16,280 | +59.11% |
| Q1 2022 | 2022-03-31 | $39,971 | −$860 | −2.11% |
| Q3 2021 | 2021-09-30 | $38,135 | — | — |
| Q2 2021 | 2021-06-30 | $27,541 | — | — |
| Q1 2021 | 2021-03-31 | $40,831 | — | — |
Bluejay Diagnostics depreciation and amortization trends
Over the last five fiscal years, Bluejay Diagnostics's depreciation and amortization decreased from $157,039 to $74,182, a change of −$82,857. The latest reported quarter, Q2 2026, shows $28,193.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bluejay Diagnostics source filings ↗